191 related articles for article (PubMed ID: 25906974)
1. Personalized versus standardized dosing strategies for the treatment of childhood amblyopia: study protocol for a randomized controlled trial.
Moseley MJ; Wallace MP; Stephens DA; Fielder AR; Smith LC; Stewart CE;
Trials; 2015 Apr; 16():189. PubMed ID: 25906974
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Amblyopia Using Personalized Dosing Strategies: Statistical Modelling and Clinical Implementation.
Wallace MP; Stewart CE; Moseley MJ; Stephens DA; Fielder AR;
Strabismus; 2016 Dec; 24(4):161-168. PubMed ID: 27929726
[TBL] [Abstract][Full Text] [Related]
3. Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS).
Stewart CE; Moseley MJ; Stephens DA; Fielder AR
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3048-54. PubMed ID: 15326120
[TBL] [Abstract][Full Text] [Related]
4. A morphological study of amblyopic eyes in children failing to achieve normal visual acuity after electronically monitored long-term occlusion treatment.
Kuhli-Hattenbach C; Koss MJ; Kohnen T; Fronius M
Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):2021-8. PubMed ID: 26100453
[TBL] [Abstract][Full Text] [Related]
5. Objectively monitored patching regimens for treatment of amblyopia: randomised trial.
Stewart CE; Stephens DA; Fielder AR; Moseley MJ;
BMJ; 2007 Oct; 335(7622):707. PubMed ID: 17855283
[TBL] [Abstract][Full Text] [Related]
6. Randomized evaluation of spectacles plus alternate-day occlusion to treat amblyopia.
Agervi P; Kugelberg U; Kugelberg M; Simonsson G; Fornander M; Zetterström C
Ophthalmology; 2010 Feb; 117(2):381-7. PubMed ID: 20006908
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of increasing patching for amblyopia.
; Wallace DK; Lazar EL; Holmes JM; Repka MX; Cotter SA; Chen AM; Kraker RT; Beck RW; Clarke MP; Lorenzana IJ; Petersen DB; Roberts JT; Suh DW
Ophthalmology; 2013 Nov; 120(11):2270-7. PubMed ID: 23755872
[TBL] [Abstract][Full Text] [Related]
8. A prospective pilot study of treatment outcomes for amblyopia associated with myopic anisometropia.
Pang Y; Allison C; Frantz KA; Block S; Goodfellow GW
Arch Ophthalmol; 2012 May; 130(5):579-84. PubMed ID: 22232365
[TBL] [Abstract][Full Text] [Related]
9. Two-year follow-up of a randomized trial of spectacles plus alternate-day patching to treat strabismic amblyopia.
Agervi P; Kugelberg U; Kugelberg M; Zetterström C
Acta Ophthalmol; 2013 Nov; 91(7):678-84. PubMed ID: 22998746
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance.
Awan M; Proudlock FA; Gottlob I
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1435-9. PubMed ID: 15790912
[TBL] [Abstract][Full Text] [Related]
11. Treatment of unilateral amblyopia: factors influencing visual outcome.
Stewart CE; Fielder AR; Stephens DA; Moseley MJ
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3152-60. PubMed ID: 16123414
[TBL] [Abstract][Full Text] [Related]
12. A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopia.
Holmes JM; Edwards AR; Beck RW; Arnold RW; Johnson DA; Klimek DL; Kraker RT; Lee KA; Lyon DW; Nosel ER; Repka MX; Sala NA; Silbert DI; Tamkins S;
J AAPOS; 2005 Apr; 9(2):129-36. PubMed ID: 15838439
[TBL] [Abstract][Full Text] [Related]
13. Clinical investigation plan for the use of interactive binocular treatment (I-BiT) for the management of anisometropic, strabismic and mixed amblyopia in children aged 3.5-12 years: a randomised controlled trial.
Brown R; Blanchfield P; Fakis A; McGraw P; Foss AJE;
Trials; 2019 Jul; 20(1):437. PubMed ID: 31311577
[TBL] [Abstract][Full Text] [Related]
14. Modeling dose-response in amblyopia: toward a child-specific treatment plan.
Stewart CE; Stephens DA; Fielder AR; Moseley MJ;
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2589-94. PubMed ID: 17525188
[TBL] [Abstract][Full Text] [Related]
15. Intense versus standard regimens of intermittent occlusion therapy for unilateral moderate amblyopia in children: study protocol for a randomized controlled trial.
Wang J; Malik A; Jin J; Pang Y; Yin K; Allen M; Grigorian A; Scombordi B; Bailey J; Aljohani S; Funari K; Shoge R; Meiyeppen S; Myung J; Soni A; Neely DE
Trials; 2020 Apr; 21(1):361. PubMed ID: 32345348
[TBL] [Abstract][Full Text] [Related]
16. Clinical translation of recommendations from randomized clinical trials on patching regimen for amblyopia.
Jin YP; Chow AH; Colpa L; Wong AM
Ophthalmology; 2013 Apr; 120(4):657-62. PubMed ID: 23395531
[TBL] [Abstract][Full Text] [Related]
17. Compliance with occlusion therapy for childhood amblyopia.
Wallace MP; Stewart CE; Moseley MJ; Stephens DA; Fielder AR; ;
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6158-66. PubMed ID: 23882695
[TBL] [Abstract][Full Text] [Related]
18. Extended optical treatment versus early patching with an intensive patching regimen in children with amblyopia in Europe (EuPatch): a multicentre, randomised controlled trial.
Proudlock FA; Hisaund M; Maconachie G; Papageorgiou E; Manouchehrinia A; Dahlmann-Noor A; Khandelwal P; Self J; Beisse C; Gottlob I;
Lancet; 2024 May; 403(10438):1766-1778. PubMed ID: 38704172
[TBL] [Abstract][Full Text] [Related]
19. Optical treatment of amblyopia in older children and adults is essential prior to enrolment in a clinical trial.
Gao TY; Anstice N; Babu RJ; Black JM; Bobier WR; Dai S; Guo CX; Hess RF; Jenkins M; Jiang Y; Kearns L; Kowal L; Lam CSY; Pang PCK; Parag V; South J; Staffieri SE; Wadham A; Walker N; Thompson B;
Ophthalmic Physiol Opt; 2018 Mar; 38(2):129-143. PubMed ID: 29356022
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of patching regimens for treatment of moderate amblyopia in children.
Repka MX; Beck RW; Holmes JM; Birch EE; Chandler DL; Cotter SA; Hertle RW; Kraker RT; Moke PS; Quinn GE; Scheiman MM;
Arch Ophthalmol; 2003 May; 121(5):603-11. PubMed ID: 12742836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
